Global Health Economist
- Market Access, Pricing and Health Economist
- Denmark - Søborg
Market access is increasingly important for the commercial success of pharmaceutical products. A key challenge for the pharmaceutical industry is to get the healthcare decision makers to support funding of innovative medicines. Such a new environment requires communicating strong value messages based on robust and credible evidence.
About the department
Global Market Access is an expanding, international, high performing team of colleagues in Søborg, Denmark, responsible for optimising market access for the continued success of the Novo Nordisk Portfolio. In close collaboration with key internal stakeholders, Global Market Access establishes the strategies and key support tactics in the area of pricing, reimbursement, health economics & outcomes research, value communication, and subsequently supports the implementation regionally and locally.
The job
In order to strengthen its capability, Global Market Access is seeking a Global Health Economist whose role will be to continue developing and facilitating the execution of health economic strategies to optimize market access for Novo Nordisk.
As a Global Health Economist, you will work cross functionally with a wide array of functions including Global Development, Medical Affairs, Brand Teams and affiliates (~20% travel). In this role you will translate clinical and health economic information to evidence-based value arguments. A key part of the job will be to prepare health economic tactics and executable tools, such as reimbursement/HTA dossiers, HE models, HE publications and other tools useful for the affiliate market access functions. Moreover you will get a chance to work with projects such as real-world data, time-trade-off, conjoint analysis, large-scale surveys. The right candidate will have opportunities to influence the strategic direction of health economic evidence for future product launches as well.
Qualifications
You hold a relevant life science or economics background, preferably with post-graduate qualifications (PhD, MSc, MPH). A solid understanding of health economics is required. Proven prior experience (minimum 3 years) within market access, health economics, stakeholder engagement or relevant field-based affiliate functions from the pharmaceutical industry and/or consulting is a plus. You have excellent analytical and project management skills and a proven ability to translate clinical and other benefits into evidence-based economic arguments and deliverables e.g. publications. In addition, you have excellent communication skills, are able to create strong networks and enjoy working in cross-functional teams. You are fluent in both written and spoken English on a professional level.
At Novo Nordisk we use our skills, dedication and ambition to help people with diabetes and change their lives. By working with us you will have the opportunity to do the same in a global business environment.
Contact
For further information, please contact Agathe Le Lay on +45 3079 3956.
Deadline
12 January 2014
- Market Access, Pricing and Health Economist
- Denmark - Søborg
Market access is increasingly important for the commercial success of pharmaceutical products. A key challenge for the pharmaceutical industry is to get the healthcare decision makers to support funding of innovative medicines. Such a new environment requires communicating strong value messages based on robust and credible evidence.
About the department
Global Market Access is an expanding, international, high performing team of colleagues in Søborg, Denmark, responsible for optimising market access for the continued success of the Novo Nordisk Portfolio. In close collaboration with key internal stakeholders, Global Market Access establishes the strategies and key support tactics in the area of pricing, reimbursement, health economics & outcomes research, value communication, and subsequently supports the implementation regionally and locally.
The job
In order to strengthen its capability, Global Market Access is seeking a Global Health Economist whose role will be to continue developing and facilitating the execution of health economic strategies to optimize market access for Novo Nordisk.
As a Global Health Economist, you will work cross functionally with a wide array of functions including Global Development, Medical Affairs, Brand Teams and affiliates (~20% travel). In this role you will translate clinical and health economic information to evidence-based value arguments. A key part of the job will be to prepare health economic tactics and executable tools, such as reimbursement/HTA dossiers, HE models, HE publications and other tools useful for the affiliate market access functions. Moreover you will get a chance to work with projects such as real-world data, time-trade-off, conjoint analysis, large-scale surveys. The right candidate will have opportunities to influence the strategic direction of health economic evidence for future product launches as well.
Qualifications
You hold a relevant life science or economics background, preferably with post-graduate qualifications (PhD, MSc, MPH). A solid understanding of health economics is required. Proven prior experience (minimum 3 years) within market access, health economics, stakeholder engagement or relevant field-based affiliate functions from the pharmaceutical industry and/or consulting is a plus. You have excellent analytical and project management skills and a proven ability to translate clinical and other benefits into evidence-based economic arguments and deliverables e.g. publications. In addition, you have excellent communication skills, are able to create strong networks and enjoy working in cross-functional teams. You are fluent in both written and spoken English on a professional level.
At Novo Nordisk we use our skills, dedication and ambition to help people with diabetes and change their lives. By working with us you will have the opportunity to do the same in a global business environment.
Contact
For further information, please contact Agathe Le Lay on +45 3079 3956.
Deadline
12 January 2014